Top brand choice
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Elonox HP, containing the active ingredient Enoxaparin, is an anticoagulant medication primarily used to prevent and treat deep vein thrombosis (DVT) and pulmonary embolism (PE). It is also commonly prescribed for patients undergoing certain types of surgery to prevent blood clots and reduce the risk of stroke in people with specific types of heart disease. Enoxaparin belongs to a class of drugs known as low molecular weight heparins (LMWH) and works by blocking the formation of blood clots. Elonox HP is available in pre-filled syringes, making administration convenient and precise.
Before you buy Enoxaparin sodium injection, it is crucial that you talk to your healthcare provider about potential side effects and Enoxaparin cost.
Fact Table | |
---|---|
Formula | C26H40N2O36S5 (approximate for Enoxaparin) |
License | FDA approved |
Bioavailability | Approximately 100% (subcutaneous injection) |
Legal status | Prescription Drugs |
Chemical Name | Enoxaparin sodium |
Elimination half-life | About 4.5 hours |
Dosage (Strength) | 40 mg/0.4 mL, 80 mg/0.8 mL, 100 mg/1 mL pre-filled syringes |
Pregnancy | Not recommended unless essential |
Brands | Elonox HP, Lovenox |
Protein binding | Less than 10% |
PubChem CID | 14779547 |
MedlinePlus | a601210 |
ChEBI | 63500 |
ATC code | B01AB05 |
DrugBank | DB01225 |
KEGG | D07794 |
Routes of administration | Subcutaneous, Intravenous |
The dosage of Elonox HP varies based on the patient's medical condition, age, weight, and response to treatment. It is crucial to follow your healthcare provider's instructions precisely.
Elonox HP is administered through subcutaneous injection. Common sites for injection include the abdominal area, ensuring at least 2 inches away from the belly button. Rotate the injection sites with each dose to minimize skin irritation. Do not inject into muscle or within bony areas. The syringe should be used immediately after opening, and any unused portion should be discarded.
Active Ingredient: Enoxaparin Sodium.
Inform your doctor if you have any history of allergies to heparin or pork products, as Enoxaparin is derived from pork intestinal mucosa.
Patients with kidney disease, diabetes, high blood pressure, or a history of stomach/intestinal problems should use Elonox HP with caution.
Discuss with your healthcare provider if you are pregnant, plan to become pregnant, or are breastfeeding, as the safety of Enoxaparin in these conditions is not fully established.
Inform your doctor if you have had or will be having surgery, especially involving the eyes, brain, or spine.
Elonox HP can interact with other medications, which can significantly impact its effectiveness and increase the risk of side effects. It is important to inform your healthcare provider of all medications you are taking, including antiplatelet agents (e.g., aspirin, clopidogrel), nonsteroidal anti-inflammatory drugs (NSAIDs; e.g., ibuprofen, naproxen), other anticoagulants (e.g., warfarin), selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs). These interactions can enhance the risk of bleeding.
While Enoxaparin injection is effective in preventing and treating blood clots, it may cause side effects in some individuals. The most common side effects include bleeding, injection site reactions, thrombocytopenia, hyperkalemia, and osteoporosis.